Aflac/$AFL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aflac
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
Ticker
$AFL
Sector
Primary listing
NYSE
Industry
Insurance
Headquarters
Employees
12,694
ISIN
US0010551028
Website
Aflac Metrics
BasicAdvanced
$55B
15.93
$6.44
0.83
$2.16
2.26%
Price and volume
Market cap
$55B
Beta
0.83
52-week high
$114.45
52-week low
$88.00
Average daily volume
2M
Dividend rate
$2.16
Financial strength
Current ratio
1.38
Quick ratio
1.235
Long term debt to equity
29.114
Total debt to equity
29.429
Dividend payout ratio (TTM)
31.03%
Interest coverage (TTM)
22.96%
Profitability
EBITDA (TTM)
4,632.25
Gross margin (TTM)
45.41%
Net profit margin (TTM)
21.27%
Operating margin (TTM)
27.19%
Effective tax rate (TTM)
18.19%
Revenue per employee (TTM)
$1,330,000
Management effectiveness
Return on assets (TTM)
2.34%
Return on equity (TTM)
14.41%
Valuation
Price to earnings (TTM)
15.927
Price to revenue (TTM)
3.372
Price to book
2.11
Price to tangible book (TTM)
2.11
Price to free cash flow (TTM)
23.275
Free cash flow yield (TTM)
4.30%
Free cash flow per share (TTM)
440.94%
Dividend yield (TTM)
2.10%
Forward dividend yield
2.26%
Growth
Revenue change (TTM)
-12.66%
Earnings per share change (TTM)
-28.90%
3-year revenue growth (CAGR)
-7.60%
10-year revenue growth (CAGR)
-2.71%
3-year earnings per share growth (CAGR)
1.79%
10-year earnings per share growth (CAGR)
7.23%
3-year dividend per share growth (CAGR)
14.38%
10-year dividend per share growth (CAGR)
10.59%
What the Analysts think about Aflac
Analyst ratings (Buy, Hold, Sell) for Aflac stock.
Bulls say / Bears say
Aflac's consistent dividend growth, including a recent 16% increase for Q1 2025, underscores its strong financial health and commitment to shareholder returns. (nasdaq.com)
The company's strategic partnerships, such as the collaboration with SKYGEN to enhance dental and vision benefits management, position Aflac to expand its product offerings and customer base. (finance.yahoo.com)
Aflac's focus on digital transformation has improved operational efficiencies and facilitated a shift to digital sales channels, potentially supporting strong profit margins in the future. (finance.yahoo.com)
Aflac reported a net loss of $93 million in the third quarter, indicating potential financial challenges. (prnewswire.com)
Analysts have given Aflac a consensus rating of 'Hold,' with some assigning 'Sell' recommendations, suggesting limited upside potential. (marketbeat.com)
Insider selling, such as the sale of 24,744 shares by EVP Audrey B. Tillman, may indicate concerns about the company's future performance. (americanbankingnews.com)
Data summarised monthly by Lightyear AI. Last updated on 28 May 2025.
Aflac Financial Performance
Revenues and expenses
Aflac Earnings Performance
Company profitability
Aflac News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aflac stock?
Aflac (AFL) has a market cap of $55B as of June 20, 2025.
What is the P/E ratio for Aflac stock?
The price to earnings (P/E) ratio for Aflac (AFL) stock is 15.93 as of June 20, 2025.
Does Aflac stock pay dividends?
Yes, the Aflac (AFL) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is $2.16 and the yield is 2.26%. Aflac has a payout ratio of 31.03% on a trailing twelve-month basis.
When is the next Aflac dividend payment date?
The next Aflac (AFL) dividend payment date is unconfirmed.
What is the beta indicator for Aflac?
Aflac (AFL) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.